Showing results (211-220 of 298) with videos related to
Sort By:
Pageof 30
Mbio|February 8, 2024
Foraminifera as a model of eukaryotic genome dynamismCaitlin Timmons, Kristine Le, H B Rappaport, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapyJ H Phillips, B T Gemlo, W W Myers, et al.Ophthalmology|May 12, 2005
A unique corneal dystrophy of Bowman's layer and stroma associated with the Gly623Asp mutation in the transforming growth factor beta-induced (TGFBI) geneAnthony J Aldave, Sylvia A Rayner, Julie A King, et al.Cancer Research|October 15, 1988
Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cellsB T Gemlo, M A Palladino, H S Jaffe, et al.Surgery|June 1, 1986
Total hepatic arterial perfusion after occlusion of variant lobar vessels: implications for hepatic arterial chemotherapyA A Rayner, R K Kerlan, R J Stagg, et al.Cancer|March 15, 1985
Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancerA A Rayner, E A Grimm, M T Lotze, et al.Investigative Ophthalmology & Visual Science|January 14, 2000
Adhesion molecule expression in a rat model of Staphylococcus aureus endophthalmitisM J Giese, D C Shum, S A Rayner, et al.Journal of the National Cancer Institute|July 1, 1985
Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumorsA A Rayner, E A Grimm, M T Lotze, et al.Oncogene|March 26, 2008
P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosisA E Sayan, B S Sayan, V Gogvadze, et al.Clinical Immunology and Immunopathology|October 1, 1991
Antigenic domains on the U1 small nuclear ribonucleoprotein-associated 70K polypeptide: a comparison of regions selectively recognized by human and mouse autoantibodies and by monoclonal antibodiesY Takeda, U Nyman, A Winkler, et al.Pageof 30